Real-world experience of the efficacy and safety of guselkumab 100 mg in patients with palmoplantar pustulosis in Korea: A retrospective single-center study
JAAD Int
.
2024 Apr 7:18:117-118.
doi: 10.1016/j.jdin.2024.02.018.
eCollection 2025 Feb.
Authors
Min Kyung Cho
1
,
Dong Hyun Kim
1
Affiliation
1
Department of Dermatology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
PMID:
39717055
PMCID:
PMC11664082
DOI:
10.1016/j.jdin.2024.02.018
No abstract available
Keywords:
biologics; guselkumab; palmoplantar pustulosis.